"While this information is theoretically available to the public, institutional owners' holdings are challenging to identify ...
A report published Tuesday shows hundreds and thousands of percent markups on HIV, hypertension and cancer drugs for Medicare ...
The U.S. Federal Trade Commission's merger-busting, antitrust enforcement powers are coming under threat as conservatives ...
"To my mind, all of this public input and engagement made our work sharper and helped us really set priorities and focus on ...
The three largest pharmacy benefit managers (PBMs) inflated the price of specialty generic drugs beyond their costs of ...
The biopharmaceutical industry is aiming for a 2025 reversal of last year's slump in investor returns but remains wary over ...
The FTC is weighing a lawsuit alleging Greystar failed to disclose fees related to trash services and background checks .
It takes effect Tuesday but its fate is already in doubt. The new FTC rule faces legal challenges and possible opposition from Trump administration.
Then Zuckerberg appeared on Joe Rogan's podcast, where the pair had a long exchange about gender roles and corporate America.
“The FTC staff’s second interim report finds that the three major pharmacy benefit managers hiked costs for a wide range of lifesaving drugs, including medications to treat heart disease and cancer,” ...
The antitrust agency recently created a rule regarding junk fees, but its application to the multifamily sector is unclear.